Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Krishina Ratna Sousa de Oliveira"'
Autor:
Melissa Quintero, Douglas Adamoski, Larissa Menezes dos Reis, Carolline Fernanda Rodrigues Ascenção, Krishina Ratna Sousa de Oliveira, Kaliandra de Almeida Gonçalves, Marília Meira Dias, Marcelo Falsarella Carazzolle, Sandra Martha Gomes Dias
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-16 (2017)
Abstract Background Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approxim
Externí odkaz:
https://doaj.org/article/da5c91a5f2b240718ff576118af417b0
Autor:
Ana Carolina Paschoalini Mafra, Carolina Aparecida de Guzzi Cassago, Marília M. Dias, Ioana Berindan-Neagoe, Carolline Fernanda Rodrigues Ascenção, Carlos H.V. Fidelis, George A. Calin, Krishina Ratna Sousa de Oliveira, Zachary E. Stine, Marcio Chaim Bajgelman, Igor M. Ferreira, Melissa Quintero, Silvana A. Rocco, Douglas Adamoski, Alliny Cristiny da Silva Bastos, Andre Luis Berteli Ambrosio, Larissa Menezes dos Reis, Sandra Martha Gomes Dias
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Many types of cancers have a well-established dependence on glutamine metabolism to support survival and growth, a process linked to glutaminase 1 (GLS) isoforms. Conversely, GLS2 variants often have tumor-suppressing activity. Triple-negative (TN) b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955095dbcd339a6b1a88cd1bba2941a2
https://doi.org/10.1038/s41388-019-1007-z
https://doi.org/10.1038/s41388-019-1007-z
Autor:
Krishina Ratna Sousa de Oliveira, Sandra Martha Gomes Dias, Marcelo Falsarella Carazzolle, Carolline Fernanda Rodrigues Ascenção, Larissa Menezes dos Reis, Douglas Adamoski, Marília M. Dias, Melissa Quintero, Kaliandra de Almeida Gonçalves
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-16 (2017)
BMC Cancer
BMC Cancer
Background Triple-negative breast cancer (TNBC) is characterized by a lack of estrogen and progesterone receptor expression (ESR and PGR, respectively) and an absence of human epithelial growth factor receptor (ERBB2) amplification. Approximately 15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc77c6a5ff4644fb5a16a2834893c264
http://link.springer.com/article/10.1186/s12885-017-3726-2
http://link.springer.com/article/10.1186/s12885-017-3726-2
Autor:
Pedro M. Moraes-Vieira, Marília M. Dias, Douglas Adamoski, Larissa Menezes dos Reis, Carolline Fernanda Rodrigues Ascenção, Sílvio Roberto Consonni, Ariel Mariano Silber, Sandra Martha Gomes Dias, Fábio Malta de Sá Patroni, Felipe Corrêa-da-Silva, Krishina Ratna Sousa de Oliveira, Rodolpho Ornitz Oliveira Souza
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
J Biol Chem
Universidade de São Paulo (USP)
instacron:USP
J Biol Chem
Triple-negative breast cancers (TNBCs) lack progesterone and estrogen receptors and do not have amplified human epidermal growth factor receptor 2, the main therapeutic targets for managing breast cancer. TNBCs have an altered metabolism, including a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ccb636f1994e78715fb03081f76db46
